These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification of complex and cryptic chromosomal rearrangements by optical genome mapping. Shi S; Huang P; Yan R; Li R Mol Cytogenet; 2023 Apr; 16(1):5. PubMed ID: 37101225 [TBL] [Abstract][Full Text] [Related]
25. Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample. Shim Y; Lee J; Seo J; Park CK; Shin S; Han H; Lee ST; Choi JR; Chung BH; Choi YD Cancer Cell Int; 2022 Oct; 22(1):306. PubMed ID: 36209207 [TBL] [Abstract][Full Text] [Related]
26. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias. Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372 [TBL] [Abstract][Full Text] [Related]
30. Optical genome mapping for structural variation analysis in hematologic malignancies. Smith AC; Neveling K; Kanagal-Shamanna R Am J Hematol; 2022 Jul; 97(7):975-982. PubMed ID: 35560245 [TBL] [Abstract][Full Text] [Related]
31. Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure. Iriondo J; Gómez A; Zubicaray J; Garcia-Martinez J; Abad L; Matesanz C; Giménez R; Galán A; Sanz A; Sebastián E; González de Pablo J; de la Cruz A; Ramírez M; Sevilla J Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790188 [TBL] [Abstract][Full Text] [Related]
32. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205). Paulraj P; Barrie E; Jackson-Cook C Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189 [TBL] [Abstract][Full Text] [Related]
33. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes. Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407 [TBL] [Abstract][Full Text] [Related]
34. Analysis of chromosomal structural variations in patients with recurrent spontaneous abortion using optical genome mapping. Rao H; Zhang H; Zou Y; Ma P; Huang T; Yuan H; Zhou J; Lu W; Li Q; Huang S; Liu Y; Yang B Front Genet; 2023; 14():1248755. PubMed ID: 37732322 [No Abstract] [Full Text] [Related]
35. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics. Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386 [TBL] [Abstract][Full Text] [Related]
36. [Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping]. Wang YF; Zhang ZH; Wang H; Xi LY; Dong F; Jing HM Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):303-307. PubMed ID: 38716605 [TBL] [Abstract][Full Text] [Related]
38. Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation. Ogiwara Y; Hattori A; Ikegawa K; Hasegawa Y; Kuroki Y; Miyado M; Fukami M Cytogenet Genome Res; 2022; 162(11-12):617-624. PubMed ID: 37231804 [TBL] [Abstract][Full Text] [Related]
39. Prospective Investigation of Optical Genome Mapping for Prenatal Genetic Diagnosis. Xie M; Zheng ZJ; Zhou Y; Zhang YX; Li Q; Tian LY; Cao J; Xu YT; Ren J; Yu Q; Wu SS; Fang S; Zhuang DY; Geng J; Chen CS; Li HB Clin Chem; 2024 Jun; 70(6):820-829. PubMed ID: 38517460 [TBL] [Abstract][Full Text] [Related]
40. The Application of Optical Genome Mapping (OGM) in Severe Short Stature Caused by Duplication of 15q14q21.3. Ke X; Yang H; Pan H; Jiang Y; Li M; Zhang H; Hao N; Zhu H Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]